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Cyto-nuclear shuttling of afadin is required for rapid estradiol-mediated
modiﬁcations of histone H3
Katherine J. Sellersa,b,1, Iain A. Watsona,b,1, Rahel E. Gresza,b, Pooja Ravala,b,
Deepak P. Srivastavaa,b,∗
a Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, UK
bMRC Centre for Neurodevelopmental Disorders, King's College London, London, SE5 9RT, UK
H I G H L I G H T S
• 17β-estradiol targets afadin to membrane and nuclear subcompartments.
• Histone H3 is rapidly phosphorylated by 17β-estradiol.
• Histone H3 phosphorylation by 17β-estradiol requires afadin nuclear accumulation.
• 17β-estradiol-mediated ERK1/2 activation is required for histone H3 phosphorylation.
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A B S T R A C T
Estrogens have been shown to rapidly regulate local signalling at synapses and within the nucleus. The result of
these signalling events is to rapidly modulate synapse structure and function, as well as epigenetic mechanisms
including histone modiﬁcations. Ultimately these mechanisms are thought to contribute to long-lasting changes
in neural circuitry, and thus inﬂuence cognitive functions such as learning and memory. However, the me-
chanisms by which estrogen-mediated local synaptic and nuclear signalling events are coordinated are not well
understood. In this study we have found that the scaﬀold protein afadin, (also known as AF-6), undergoes a bi-
directional traﬃcking to both synaptic and nuclear compartment in response to acute 17β-estradiol (estradiol)
treatment, in mixed sex neuronal cultures derived from fetal cortex. Interestingly, nuclear accumulation of
afadin was coincidental with an increase in the phosphorylation of histone H3 at serine 10 (H3S10p). This
epigenetic modiﬁcation is associated with the remodeling of chromatin into an open euchromatin state, allowing
for transcriptional activation and related learning and memory processes. Critically, the cyto-nuclear traﬃcking
of afadin was required for estradiol-dependent H3S10p. We further determined that nuclear accumulation of
afadin is suﬃcient to induce phosphorylation of the mitogentic kinases ERK1/2 (pERK1/2) within the nucleus.
Moreover, nuclear pERK1/2 was required for estradiol-dependent H3S10p. Taken together, we propose a model
whereby estradiol induces the bi-directional traﬃcking of afadin to synaptic and nuclear sub-compartments.
Within the nucleus, afadin is required for increased pERK1/2 which in turn is required for H3S10p. Therefore
this represents a mechanism through which estrogens may be able to coordinate both synaptic and nucleosomal
events within the same neuronal population.
1. Introduction
It is now well accepted that estrogens, and in particular 17β-estra-
diol (estradiol), can elicit rapid signalling actions in a range of cell
types, including neurons (Choleris et al., 2018; McEwen and Alves,
1999; Srivastava et al., 2013). The rapid “non-canonical” actions of
estrogens are reliant on the activation of speciﬁc intracellular signalling
pathways, and can inﬂuence a range of cellular events (Choleris et al.,
2018; Sellers et al., 2015a). This includes the remodeling of dendritic
spines, the traﬃcking and post-translational modiﬁcations of proteins
(Sellers et al., 2015b; Srivastava et al., 2008, 2010), as well as tran-
scriptional and epigenetic mechanisms (Boulware et al., 2005; Zhao
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et al., 2010, 2012). Importantly, the rapid modulation of these non-
canonical mechanism have been shown to be crucial for the con-
solidation of new memories (Choleris et al., 2018; Luine and Frankfurt,
2012; Srivastava et al., 2013). Of these mechanisms, the regulation of
epigenetic modiﬁcations is thought to be key in translating estradiol's
cellular eﬀects into long-lasting inﬂuences on memory (Fortress and
Frick, 2014; Zhao et al., 2010, 2012).
There is accumulating evidence that post-translational modiﬁca-
tions of histone proteins is a critical mechanisms for the remodeling of
chromatin (Watson and Tsai, 2017). The phosphorylation or acetylation
of histones is associated with the initiation of gene transcription
(Berger, 2007), and are thought of as essential transcriptional reg-
ulatory mechanisms (Maze et al., 2013; Riccio, 2010; Watson and Tsai,
2017), which in turn have been shown to be required for long-lasting
changes in behaviour. Interestingly, estradiol has been shown to cause
acetylation of Histone H3 within 5min in hippocampal neurons, which
was necessary for estrogen-dependent consolidation of memory (Zhao
et al., 2010, 2012). Another modiﬁcation important for memory and
that can be induced in response to multiple extracellular stimuli is the
phosphorylation of histone H3 protein at serine 10 on its N-terminal tail
(Brami-Cherrier et al., 2007; Lubin and Sweatt, 2007; VanLeeuwen
et al., 2014; Wittmann et al., 2009). Although such modiﬁcations are
thought to be important for the encoding of long-lasting memories, the
synaptic and cytoplasmic signalling cascades that connect local sig-
nalling at synapses with these nucleosomal events are not fully under-
stood (Fainzilber et al., 2011). Furthermore, it is not fully understood
whether estradiol regulates this epigenetic modiﬁcation.
Recently it have become apparent that proteins residing at synaptic
or cytoplasmic locations can translocate to the nucleus in response to
speciﬁc stimuli (Ch'ng and Martin, 2011; Fainzilber et al., 2011; Jordan
and Kreutz, 2009). Proteins exhibiting this form of traﬃcking are re-
ferred to as undergoing cyto- or synatpo-nuclear traﬃcking/transloca-
tion. It has been proposed that upon nuclear accumulation, that pro-
teins undergoing cyto/synapto-nuclear translocation participate in
nuclear events that result in gene expression changes, thus contributing
to long-term alterations of synapses (Ch'ng et al., 2012; Fainzilber et al.,
2011; Karpova et al., 2013). Indeed, growing evidence indicates that
this is achieved through the modiﬁcation of histone proteins. Recently,
we have shown that the scaﬀold protein afadin, (also known as AF-6),
bi-directionally traﬃcs to nuclear and synaptic sub-compartments in
response to activity-dependent stimulation (VanLeeuwen et al., 2014).
Importantly, the accumulation of nuclear afadin was required for both
long-lasting changes in synaptic morphology and time-dependent
phosphorylation of histone H3 (VanLeeuwen et al., 2014). Interestingly,
estradiol has been demonstrated to traﬃc afadin to synaptic locations
(Srivastava et al., 2008). However, it is not known if estrogen also
causes the traﬃcking of afadin to the nucleus, and additionally whether
this action can inﬂuence the post-translational modiﬁcation of histone
H3. In the present study we have examined the nuclear content of
afadin following acute exposure to estradiol. Furthermore, we have
investigated whether estradiol can phosphorylate H3 at serine 10
(H3S10p), and whether this nucelosomal event requires afadin and the
activation of the mitogenic kinase ERK1/2. Our data indicates that an
afadin/ERK1/2 pathway is required for the rapid modulation of
H3S10p by estradiol.
2. Materials and methods
2.1. Reagents and plasmid constructs
The following antibodies were purchased: GFP mouse monoclonal
(MAB3580: 1:1000), NeuN mouse monoclonal (clone A60; MAB377:
1:500), phospho-histone H3 serine 10 mouse (H3S10p) monoclonal
(clone 3H10; 05–806: 1:200) and myc rabbit polyclonal (06–549:
1:500) were from Millipore; phospho-p44/42 MAPK (ERK1/2; Thr202/
Tyr204) rabbit monoclonal (D13.14.4E; #4370: 1:1000/1:500), ERK1/
2 mouse monoclonal (L34F12; #4696: 1:1000) were from Cell
Signalling Technologies; GFP chicken polyclonal (ab13972: 1:10,000)
and histone 3 (total) rabbit polyclonal (ab1791: 1:2000) were from
Abcam; myc mouse monoclonal (9E10; Developmental Studies
Hybridoma Bank, Iowa: 1:200); L/S-afadin rabbit polyclonal (AF-6;
A0224: 1:1000/1:750), β-actin mouse monoclonal (clone AC-74;
A5316: 1:1000) were from Sigma; DAPI was from Life Technologies.
The speciﬁcity of the L/S afadin antibody has been previously de-
monstrated by shRNA knockdown and in two independent conditional
knockout animals (Gao et al., 2017; Srivastava et al., 2012; Yoshida
et al., 2014). Estradiol (17β-estradiol) (E8875) was from Sigma; kinase
inhibitor U0126 (MEK kinase inhibitor) (9903S) was from Cell Signal-
ling Technologies. Plasmids used in this study were myc-l-afadin, and
myc-afadin-NT which have been previously described (Xie et al., 2005).
2.2. Neuronal culture and transfections
Mixed sex cortical neuronal cultures were prepared from Sprague-
Dawley rat E18 embryos as described previously (Srivastava et al.,
2011). Animals were habituated for 3 days before experimental pro-
cedures, which were carried out in accordance with the Home Oﬃce
Animals (Scientiﬁc procedures) Act, United Kingdom, 1986. All animal
experiments were given ethical approval by the ethics committee of
King's College London (United Kingdom). Cells were plated onto 18mm
glass coverslips (No 1.5; 0117580, Marienfeld-Superior GmbH & Co.),
coated with poly-D-lysine (0.2 mg/ml, Sigma), at a density of 3×105/
well equal to 857/mm2. Neurons were cultured in feeding media:
neurobasal medium (21103049) supplemented with 2% B27
(17504044), 0.5 mM glutamine (25030024) and 1% penicillin:strepto-
mycin (15070063) (all reagents from Life technologies). It should be
noted that the neurobasal media contains phenol red, a compound with
known estrogenic activity. Neuron cultures were maintained in pre-
sence of 200 μM D,L-amino-phosphonovalerate (D,L-APV, ab120004,
Abcam) beginning on DIV (days in vitro) 4 in order to maintain neuronal
health for long-term culturing and to reduce cell death due to excessive
Ca2+ cytotoxicity via over-active NMDA receptors (Srivastava et al.,
2011). We have previously shown that the presence or absence of APV
in the culture media does not aﬀect E2's ability to increase spine linear
density (Srivastava et al., 2008). Half media changes were performed
twice weekly until desired age (DIV 23–25). The primary cortical
neurons were transfected with the appropriate plasmid at DIV 23 for 2
days, using Lipofectamine 2000 (11668027, Life Technologies)
(Srivastava et al., 2011). Brieﬂy, 4–6 μg of plasmid DNA was mixed
with Lipofectamine 2000 and incubated for 4–12 h, before being re-
placed with fresh feeding media. Transfections were allowed to proceed
for 2 days, after which cells were used for pharmacological treatment or
ICC.
2.3. Pharmacological treatments of neuron culture
All pharmacological treatments were performed in artiﬁcial cerebral
spinal ﬂuid (aCSF): (in mM) 125 NaCl, 2.5 KCL, 26.2 NaHCO3, 1
NaH2PO4, 11 glucose, 5 Hepes, 2.5 CaCl2, 1.25 MgCl2, and 0.2 APV).
ACSF was used to ensured that there were no interactions between the
pharmacological compounds being used and unknown elements within
the culture media that may indirectly aﬀect the experimental outcome.
For kinase inhibitor experiments, neurons were pre-treated for 30min
before application of E2 directly over neurons. All compounds were
dissolved in either 100% ethanol or DMSO at a concentration of 10 or
1mM, serially diluted to a 10X working concentration in aCSF, and
applied directly to neuronal cultures. Final concentration of solvent
was< 0.01%: vehicle control was made up of solvent lacking com-
pound diluted as test compounds. Treatments were allowed to proceed
for indicated time before being lysed for Western blotting or ﬁxed for
immunocytochemistry (ICC).
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2.4. Immunocytohistochemistry (ICC)
Neurons were ﬁxed in either 4% formaldehyde/4% sucrose PBS for
10min, or in 4% formaldehyde/4% sucrose PBS followed by 10min ﬁx
with Methanol pre-chilled to −20 °C. Coverslips were then permeabi-
lised and blocked simultaneously in PBS containing 2% normal goat
serum and 0.2% Triton-X-100 for 1 h at room temperature. Primary
antibodies were added in PBS containing 2% normal goat serum for
2 h at room temperature, or overnight at 4 °C, followed by 3× 10min
washes in PBS. Secondary antibodies were incubated for 1 h at room
temp, also in 2% normal goat serum in PBS. Three further washes
(15min each) were performed before cells were incubated in DAPI if
required. Finally, coverslips were mounted using ProLong antifade re-
agent (Life Technologies).
2.5. Quantitative analysis of nuclear immunoﬂuorescence
Confocal images of double-stained neurons were acquired with a
Leica SP-5 confocal microscope using a 63× oil-immersion objective
(Leica, N.A. 1.4) as a z-series, or with a Zeiss Axio Imager Z1, equipped
with an ApoTome using a 63× oil-immersion objective (Carl Zeiss, N.A.
1.4). Two-dimensional maximum projection reconstructions of images
were generated and linear density calculated using ImageJ/Fiji
(https://imagej.nih.gov/ij/) (Srivastava et al., 2011). For measure-
ments of nuclear protein content, regions were drawn around nuclei, as
delineated by NeuN or DAPI staining, and saved as regions of interest
(ROI). These ROI were then applied to a corresponding image of afadin
staining from which the mean average intensity was collected to de-
termine nuclear immunoreactivity levels. Immunoreactivity levels of
the nuclear localised proteins H3S10p or pERK1/2 were also measured
within the nuclear ROI. Images were selected by examining a z stack
series of images through the nucleus and choosing a central/re-
presentative plane. Cultures directly compared were stained simulta-
neously and imaged with the same acquisition parameters. For each
condition, 10–16 neurons from at least 3 separate experiments were
used. Experiments were carried out blind to condition and on sister
cultures.
2.6. Quantitative analysis of synaptic and dendritic immunoﬂuorescence
Synaptic and dendritic localization of afadin was quantiﬁed using
MetaMorph (Srivastava et al., 2011). Images were acquired as de-
scribed above. The background corresponding to areas without cells
were subtracted to generate a “background-subtracted” image. Images
were then thresholded equally to include clusters with intensity at least
twofold above the adjacent dendrite. Regions along dendrites were
outlined using the “Parameters” utility and the total grey value (im-
munoﬂuorescence integrated intensity) of each cluster, or all clusters
within a region were measured automatically. Quantiﬁcation was per-
formed as detailed above.
2.7. Biochemistry cell fractionation
Subcellular fractions were prepared using the Proteo-Extract kit
(EMD Biosciences) following the manufacturer's recommendations.
Lysates were subjected to Western blotting; membranes were probed
with the appropriate antibodies. Histone enriched nuclear fractions
were prepared as follows. Treated neurons were collected in 150 μL ice
cold homogenisation buﬀer: 320mM sucrose; 5 mM Na4P2O7; 1mM
EDTA pH 8; and 10mM HEPES pH 7.4 in the presence of protease and
phosphatase inhibitors and homogenised by passage through a 25
gauge needle 12 times. The lysate was centrifuged at 800× g for
10min at 4 °C to yield the P1 (nuclear) fraction. P1 fractions were then
resuspended in triton extraction buﬀer (TEB): PBS containing 0.5%
Triton ×100, 2mM AEBSF and 0.02% (w/v) NaN3. Nuclear fractions
were left on ice for 10min before centrifugation at 6500× g at 4 °C;
resulting pellet was retained and washed in TEB, subject to cen-
trifugation before being resuspended in 0.2M HCl overnight at 4 °C.
Samples were then centrifuged at 6500×g at 4 °C and supernatant
collected; HCl was neutralised with 2M NaOH. Histone enriched nu-
clear fractions were then subjected to Western blotting; membranes
were probed with appropriate histone antibodies.
2.8. Statistical analysis
All statistical analysis was performed in GraphPad. Diﬀerences in
quantitative immunoﬂuorescence, dendritic spine number were iden-
tiﬁed by Student's unpaired t-tests. For comparisons between multiple
conditions, the main eﬀects and simple eﬀects were probed by one-way-
ANOVAs followed by Tukey Post Hoc analysis. Error bars represent
standard errors of the mean. Between 3 and 5 independent cultures
were used for all experiments.
3. Results
3.1. Acute estradiol treatment causes bi-directional traﬃcking of afadin
Previous studies have demonstrated that afadin is a dual residency
protein present in both nuclear and cytosolic compartments, and spe-
ciﬁcally at synapses (Buchert et al., 2007; VanLeeuwen et al., 2014).
Moreover, we have recently shown than activity-dependent signalling
causes bi-directional traﬃcking of afadin to discrete nuclear and sy-
naptic sites within the same cell (VanLeeuwen et al., 2014). As acute
exposure to estradiol has been shown to also cause the enrichment of
afadin at synapses (Srivastava et al., 2008), we reasoned that estradiol
may also cause afadin to traﬃc to the nucleus within the same cell. To
test this, we treated primary cortical neurons with vehicle or 10 nM
estradiol for 30min and assessed afadin content within the nucleus and
along dendrites in the same cell population. The speciﬁcity of the L/S-
afadin antibody was conﬁrmed by utilising a previously described
shRNAi against afadin (Srivastava et al., 2012) (Supplementary Fig. 1A
and B). Following treatment with estradiol, afadin nuclear content was
signiﬁcantly higher than in vehicle treated cells (Fig. 1 A and B). Afadin
was congruently found to cluster along MAP2-positive dendrites (Fig. 1
A and B). Interestingly, afadin was particularly enriched in puncta
juxtaposed to MAP2-positive dendrites, indicative of an enrichment at
synapses (Fig. 1 A). We further validated these observations by per-
forming western blotting on membrane and nuclear fractions generated
from treated neurons. Consistent with our immunocytochemical data,
both long- and short- (l-, s-) afadin isoforms were increased in mem-
brane and nuclear fractions following treatment with estradiol (Fig. 1
C + D). Importantly, when we examined l/s-afadin levels in whole cell
lysates, no diﬀerence in overall expression levels were found (Fig. 1 E
and F), suggesting that the clustering of l/s-afadin within membrane/
synaptic and nuclear compartments following estradiol treatment was
due to a redistribution of the protein as opposed to an increase in
protein expression. Taken together, these data support a model where l/
s-afadin is bi-directionally traﬃcked to nuclear and synaptic sites
within the same cells following acute estradiol stimulation.
3.2. Estradiol rapidly incudes phosphorylation of histone H3
The rapid post-translational modiﬁcation of H3 has been observed
in response to synaptic activity as well as neuromodulators (Brami-
Cherrier et al., 2007; Stipanovich et al., 2008; VanLeeuwen et al., 2014;
Wittmann et al., 2009). In particular, modulation of H3S10p by these
stimuli is thought to link extracellular signals with chromatin re-
modeling, and thus the regulation of genes associated with learning and
memory (Maze et al., 2013; Riccio, 2010; Watson and Tsai, 2017).
H3S10p is tightly regulated by mitogenic-kinases and is thought to be
indicative of an open euchromatin state associated with transcriptional
activation (Berger, 2007; Brami-Cherrier et al., 2009; Watson and Tsai,
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2017). Interestingly, estradiol has been shown to modulate H3S10p via
the Aurora kinase family to control cell proliferation in ovarian and
tumour cells (Mann et al., 2011; Ruiz-Cortes et al., 2005). As estradiol
has been shown to regulate a range of histone modiﬁcation in neurons
(Fortress and Frick, 2014), we were interested in understanding whe-
ther this estrogen could also rapidly regulate H3S10p levels. Re-
markably, we observed a signiﬁcant increase in H3S10p levels after just
30 min of treatment with estradiol (Fig. 2 A and B). We validated this
result by examining H3S10p level in histone enriched nuclear fractions
generated from vehicle or estradiol treated cells. Consistent with our
ICC data, we found a signiﬁcant increase in H3S10p levels in samples
treated with estradiol (Fig. 2 C and D).
Next we investigated whether H3S10p was associated with the cyto-
nuclear shuttling of afadin, as the presence of this scaﬀold protein in the
nucleus is required for activity-dependent phosphorylation of H3 at
serine 10 (VanLeeuwen et al., 2014). Therefore, we assessed whether
estradiol caused a concomitant increase in both afadin and H3S10p
levels within the same cells. When we limited our analysis only to
neurons that demonstrated an increase in nuclear afadin compared to
control, a signiﬁcant increase in H3S10p levels was observed (Fig. 3 A
and B). Conversely, afadin-negative cells did not show the same in-
crease in H3S10p (Fig. 3 A and B). Taken together, these data indicate
that estradiol rapidly phosphorylates the N-terminal tail of H3 at serine
10, and that this modiﬁcation occurs predominately in neurons in
which afadin traﬃcs to the nucleus.
3.3. Estradiol-dependent phosphorylation of H3 is dependent on afadin
Our data above suggest a relationship between afadin traﬃcking to
the nucleus and H3S10p. This observation is consistent with the re-
quirement of increased nuclear afadin for activity-dependent H3S10p
(VanLeeuwen et al., 2014). Therefore, to prevent the accumulation of
afadin in the nucleus, we took advantage of the fact that the N-terminal
region of afadin (afadin-NT) is required for the nuclear localization of
the protein, and that exogenous expression of a myc-afadin-NT frag-
ment blocks activity-dependent cytonuclear traﬃcking of endogenous
afadin (VanLeeuwen et al., 2014). We ﬁrst conﬁrmed whether exo-
genous myc-afadin-NT could block estradiol-induced nuclear accumu-
lation of afadin. Indeed we found that following treatment with estra-
diol, cells expressing myc-afadin-NT had an attenuated level of nuclear
afadin compared to non-expressing cells (Fig. 4 A and B). Interestingly,
expression of the NT fragment did not alter levels of endogenous nu-
clear afadin under vehicle conditions (Fig. 4 A and B), indicating that
exogenous afadin-NT was only blocking the active transport of en-
dogenous afadin into the nucleus. Next we treated neurons with es-
tradiol or vehicle and examined whether exogenous myc-afadin-NT
could block estradiol-induced H3S10p. Under basal conditions (Veh),
exogenous afadin-NT did not alter H3S10p levels compared to non-
Fig. 1. Estradiol induces the rapid bi-directional traﬃcking of afadin to synaptic and nuclear subcompartments. (A) Representative confocal images of DIV
23 cortical neurons treated with vehicle or 10 nM estradiol for 30min. Insets show magniﬁed regions of cell body including nucleus (‘(i)’, yellow box) (deﬁned by
DAPI staining) or dendrites (‘(ii)’, yellow rectangle) or within the same neuron. Pseudo images are of endogenous afadin content: yellow circles indicate the nucleus;
white arrow heads indicate synaptic afadin puncta. (B) Quantiﬁcation of afadin content at nuclear or synaptic subcompartments. Treatment with estradiol (30 min)
causes a signiﬁcant increase in afadin presence at both regions (***, p < 0.001, Student t-test; n = 80–81 cell per condition from 5 independent cultures). (C)
Western blot analysis of membrane or nuclear cell fractions following treatment with vehicle or estradiol (also referred to as E2 in this ﬁgure). Blots were probed with
an antibody that detects long- (l-) and short- (s-) afadin isoforms; β-actin was used a loading control and NeuN (Rbfox3) was used to conﬁrm enrichment of nuclear
compartment. (D) Quantiﬁcation of l/s-afadin revealed an increase in both isoforms in membrane and nuclear fractions following treatment with estradiol (*,
p < 0.05, **, p < 0.01, Student t-test; n = 3 independent cultures). (E and F) Assessment of afadin expression in whole cell following treatment with vehicle or
estradiol reveals that there is no change in overall expression of the scaﬀold protein (Student t-test; n= 3 independent cultures). Scale bars= 20 μm, (i) 10 μm, (ii)
5 μm. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the Web version of this article.)
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Fig. 2. Estradiol-mediated histone H3 phos-
phorylation at serine 10 (H3S10p). (A)
Representative confocal images of DIV 23 cor-
tical neurons immunostained for MAP2 (mor-
phological marker) and H3S10p; nucleus was
identiﬁed by DAPI, after treatment with vehicle
or estradiol (10 nM) for 30min. Insets (yellow
box) show magniﬁed regions of cell body in-
cluding nucleus deﬁned by DAPI staining
(yellow circle). Pseudo images are of en-
dogenous H3S10p levels: ‘hot’ colours indicate
increased expression. (B) Quantiﬁcation of
H3A10p levels reveals that estradiol treatment
increases H3 phosphorylation (**, p < 0.01,
Student t-test; n = 47–48 cells per condition
from 4 independent cultures). (C) Western blot
analysis of H3S10p levels in histone enriched
nuclear fractions following treatment with ve-
hicle or estradiol (also referred to as E2 in this
ﬁgure). Blots were probed for H3S10p and total
H3 proteins; total H3 was used as the loading
control. (D) Quantiﬁcation of H3S10p revealed
an increase in phosphorylated H3 following
treatment with estradiol (**, p < 0.01, Student
t-test; n = 3 independent cultures). (For inter-
pretation of the references to colour in this
ﬁgure legend, the reader is referred to the Web
version of this article.)
Fig. 3. Estradiol increased H3S10p levels and
afadin nuclear accumulation occur within
the same population of neurons. (A) Confocal
images of DIV 24 cortical neurons treated with
vehicle or estradiol and subsequently im-
munostained with afadin and H3S10p: DAPI was
used to deﬁne nucleus. Insets (yellow box) show
magniﬁed regions of cell body including nucleus
(yellow circle). Pseudo images are of en-
dogenous H3S10p levels: ‘hot’ colours indicate
increased expression. Representative images are
of vehicle treated cells and treated cells dis-
playing either an increased afadin nuclear con-
tent (compared to vehicle: afadin-positive(+
+)) or not (afadin-negative(–)). (B) Analysis of
H3S10p levels was performed in afadin-positive
and negative cells separately. This analysis re-
vealed that H3S10p was increased following
estradiol treatment in neurons that concurrently
display an increase in afadin nuclear content.
Afadin-negative cells did not display an increase
in H3S10p, however a large spread of data point
potentially indicates a subset of cells respond in
the absence of increased afadin nuclear pre-
sence. Box and whisker plots with min/max bars
are used to display spread of data; (*, p < 0.05,
Student t-test; n = 25–28 cells per condition
from 3 independent cultures). Scale
bar = 10 μm; 5 μm. (For interpretation of the
references to colour in this ﬁgure legend, the
reader is referred to the Web version of this ar-
ticle.)
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expressing cells. However, following treatment with estradiol, cells
expressing afadin-NT no longer demonstrated an increase in H3S10p
levels (Fig. 4 C and D). Taken together, these data suggest that the
traﬃcking of afadin to the nucleus is required for estradiol-dependent
phosphorylation of H3 at serine 10.
3.4. Acute estradiol treatment phosphorylates ERK1/2 in nucleus
One of the major kinases that mediates the rapid eﬀects of estradiol
is the mitogenic kinases, ERK1/2 (Choleris et al., 2018; Sellers et al.,
2015a). Interestingly, it has been reported that estradiol and speciﬁc
estrogen receptor agonists can activate ERK1/2 via phosphorylation
(pERK1/2) at multiple cellular compartments such as synapses and the
nucleus (Mannella and Brinton, 2006; Srivastava et al., 2008, 2010).
Consistent with this, we observed increased pERK1/2 levels along, and
juxtaposed to dendrites, as well as within the nucleus after 30min of
estradiol treatment (Fig. 5 A and B). To conﬁrm these ﬁndings, we also
probed nuclear fractions for pERK1/2 by western blot. This further
demonstrated that estradiol could rapidly increase pERK1/2 levels in
the nucleus (Fig. 5 C and D). Afadin is a component of the Rap/Ras
signalling cascade, and therefore is thought to mediate Ras/Rap's
ability to signal to its downstream targets, which includes ERK1/2
(Woolfrey and Srivastava, 2016; Ye and Carew, 2010). We therefore
reasoned that afadin, a target of Rap signalling (Xie et al., 2005;
Srivastava et al., 2012), may also be important for the activation of
ERK1/2 in both dendritic and nuclear compartments. Indeed, over-
expression of full length myc-l-afadin resulted in a signiﬁcant increase
in pERK1/2 levels (Fig. 5 E). Interestingly, increased pERK1/2 could be
observed along dendrites and synapses, but also within the cell soma
and nucleus (Fig. 5 E and F). Taken together, these data support a
Fig. 4. Cyto-nuclear traﬃcking of afadin is
required for estradiol-induced increased
H3S10p expression. (A) Representative con-
focal images of DIV 25 cortical neurons exo-
genously myc-afadin-NT, or not, treated with
vehicle or estradiol (E2; 10 nM, 30min), and
subsequently ﬁxed and immunostained for
afadin and myc; nucleus was deﬁned by DAPI
(green circle). (B) Analysis of afadin nuclear
content revealed that under basal conditions
(vehicle treatment), afadin-NT did not alter
afadin content in the nucleus. Conversely,
afadin-NT attenuated estradiol-mediated afadin
nuclear accumulation (F(3,41) = 17.77,
p < 0.001, Tukey Post Hoc, ***, p < 0.001,
one-way ANOVA; n = 10–13 cells per condition
from 3 independent cultures). (C) Confocal
images of DIV 25 cortical neurons over-
expressing myc-afadin-NT, or not, and treated
with vehicle or estradiol (E2; 10 nM, 30min).
Neurons were ﬁxed and subsequently im-
munostained for H3S10p and myc; nucleus was
deﬁned by DAPI (green circle). (D)
Quantiﬁcation of H3S10p levels following
treatment revealed that exogenous afadin-NT
reduced estradiol-mediated increased H3S10p
expression (F(3,120) = 19.11, p < 0.001,
Tukey Post Hoc, ***, p < 0.001, one-way
ANOVA; n = 20–50 cells per condition from 3
independent cultures). Scale bars = 5 μm. (For
interpretation of the references to colour in this
ﬁgure legend, the reader is referred to the Web
version of this article.)
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model whereby estradiol increases ERK1/2 activation within multiple
cellular compartments including the nucleus. Furthermore, afadin may
play a role in mediating the subcompartment activation of ERK1/2.
3.5. Estradiol-induced H3S10p requires ERK1/2 phosphorylation
As estradiol rapidly increased pERK1/2 levels in the nucleus, we
reasoned that this kinase may be part of the pathway resulting in in-
creased H3S10p levels. Consistent with this, the mitogenic kinases
MSK1 and RSK1, which directly phosphorylate H3 at serine 10, are
direct targets of ERK1/2 (Bluthgen et al., 2017; Brami-Cherrier et al.,
2009; Chwang et al., 2006; Ciccarelli and Giustetto, 2014). Therefore,
we tested whether estradiol-mediated H3S10p could be blocked by
inhibiting pERK1/2 using the MEK kinase inhibitor U0126. Pretreat-
ment with U0126 alone had no eﬀect on basal levels of H3S10p levels
(Fig. 6 A and B). However, pretreatment with U0126 signiﬁcantly
attenuated the ability of estradiol to increase H3S10p levels (Fig. 6 A
and B). Collectively, these data indicate that estradiol can rapidly in-
crease H3S10p via an ERK1/2-dependent pathway.
4. Discussion
In this study we have demonstrated that estradiol causes the bi-di-
rectional traﬃcking of afadin to synaptic and nuclear compartments
within the same cell. Furthermore, we present evidence that estradiol
phosphorylates histone H3 at serine 10, which is dependent on the
nuclear accumulation of afadin. Interestingly, estradiol also caused an
increase in pERK1/2 levels within the nucleus, which was mimicked by
the overexpression of l-afadin. Moreover, we found that the MEK/
ERK1/2 signalling cascade was required for estradiol-dependent in-
creases in H3S10p levels. Taken together, we propose a model where
afadin is bi-directional traﬃcked to synaptic/membrane regions and
Fig. 5. Estradiol rapidly phosphorylates nu-
clear ERK1/2. (A) Confocal images of DIV 25
cortical neurons treated with vehicle or estradiol
(E2; 10 nM, 30min), and subsequently ﬁxed and
immunostained for pERK1/2; nucleus was de-
ﬁned by DAPI (green circle). Pseudo images are
of endogenous pERK1/2 levels: ‘hot’ colours in-
dicate increased expression. (B) Quantiﬁcation
of pERK1/2 nuclear level revealed a signiﬁcant
increase in expression following estradiol treat-
ment. (***, p < 0.001, Student t-test;
n = 18–23 cell per condition from 3 in-
dependent cultures). (C) Western blotting of
nuclear fraction of neurons treated with vehicle
or estradiol (30min): blots were probed for
phospho and total ERK1/2; histone H3 was used
to conﬁrm enrichment of nuclear compartment.
(D) Quantiﬁcation revealed that estradiol
caused a signiﬁcant increase in pERK1/2 ex-
pression (*, p < 0.05,Student t-test; n = 3 in-
dependent cultures). (E) Representative con-
focal images of DIV 25 cortical neurons
ectopically expressing myc-L-afadin or not and
immunostained for myc or pERK1/2: nucleus
was identiﬁed by DAPI. Pseudo images are of
endogenous pERK1/2 levels: ‘hot’ colours in-
dicate increased expression. Cells expressing
myc-L-afadin demsontrated increased pERK1/2
levels along dendrites (yellow arrow heads) and
within the nucleus. (F) Quantiﬁcation of
pERK1/2 expression in nuclear and dendritic/
synaptic subcompartment reveals that in the
presence of myc-l-afadin, there is a signﬁncant
increase in ERK1/2 phosphorylation in both re-
gions (***, p < 0.001,Student t-test;
n = 10–12 cells, from 3 independent cultures).
Scale bars = 10 μm or 5 μm. (For interpretation
of the references to colour in this ﬁgure legend,
the reader is referred to the Web version of this
article.)
K.J. Sellers et al. Neuropharmacology 143 (2018) 153–162
159
the nucleus in response to estradiol stimulation; in the nucleus, afadin is
mediates estradiol-mediated increases in nuclear pERK1/2 and H3S10p
(Fig. 6 C). This pathway may, therefore, represent a novel mechanism
by which estrogens can rapidly remodel chromatin structure, and po-
tentially regulate gene expression in a non-canonical manner.
The molecular mechanisms that enable neurons to translate signals
generated at dendrites and synapses to the nucleus in order to regulate
nucleosomal events are not well understood (Ch'ng and Martin, 2011;
Cohen and Greenberg, 2008; Jordan and Kreutz, 2009). One me-
chanism by which signals initiated at the synapse can be propagated to
the nucleus is through the propagation of by calcium signalling (Cohen
and Greenberg, 2008). However, there is now growing evidence that
the cyto/synapto -nuclear shuttling of proteins provides another me-
chanism of signalling to the nucleus. (Ch'ng and Martin, 2011;
Fainzilber et al., 2011; Jordan and Kreutz, 2009). Although this sig-
nalling modality is slower than the propagation of calcium signals to
the nucleus, it potentially oﬀers greater speciﬁcity and temporal reg-
ulation. Indeed, several proteins that display dual localization in the
cytosol and nucleus of pyramidal neurons translocate to the nucleus
following activation of NMDARs (Abe and Takeichi, 2007; Ch'ng et al.,
2012; Dieterich et al., 2008; Jordan et al., 2007; Karpova et al., 2013;
Proepper et al., 2007; VanLeeuwen et al., 2014). Once within the nu-
cleus, these proteins may mediate gene transcription through the re-
cruitment of diﬀerent transcription factors, or indeed regulate post-
translational modiﬁcations of histone proteins. Interestingly, this
modality may also oﬀer a level of temporal regulation that may not be
possible by relying solely on calcium signalling. For example, we have
previously shown that afadin shuttles to the nucleus and regulates
H3S10p levels via a p90RSK-dependent mechanism in response to ac-
tivity-dependent stimulation. However, this pathway was only required
for the phosphorylation of H3 after 120min of stimulation, and not at
earlier time points (VanLeeuwen et al., 2014).
The data we present in the study above is consistent with our pre-
vious work whereby following stimulation, afadin is traﬃcked to sy-
naptic/membrane subcompartments, but also shuttles to the nucleus
within the same cell (Srivastava et al., 2008; VanLeeuwen et al., 2014).
We have proposed that this bi-directional traﬃcking of afadin poten-
tially arises from two separate pools of protein (VanLeeuwen et al.,
2014). These distinct populations allow this protein to engage with
local signalling events at synapses in addition to regulation of
Fig. 6. ERK1/2 activation is required for estra-
diol-dependent increased H3S10p expression. (A)
Confocal images of DIV 23 cortical neurons pre-
treated with MEK inhibitor, U0126 (10 μM for
20min) or control, before being treated with vehicle
or estradiol (E2; 10 nM, 30min), and subsequently
ﬁxed and immunostained for H3S10p; nucleus was
deﬁned by DAPI (green circle). Pseudo images are of
endogenous H3S10p levels: ‘hot’ colours indicate
increased expression. (B) Quantiﬁcation revealed
that pre-incubation with U0126 blocked estradiol-
mediated increased H3S10p expression (F
(3,104) = 10.01, p < 0.001, Tukey Post Hoc, ***,
p < 0.001, one-way ANOVA, n = 24–29 cell per
condition from 3 independent cultures). (C)Model of
estradiol's ability to coordinate synaptic and nuclear
signalling. Scale bar= 5 μm. (For interpretation of
the references to colour in this ﬁgure legend, the
reader is referred to the Web version of this article.)
K.J. Sellers et al. Neuropharmacology 143 (2018) 153–162
160
nucleosomal events (Fig. 5 C). Consistent with this idea, we and others
have previously shown that afadin is required for the maintenance of
synaptic structure as well as excitatory tone (Beaudoin et al., 2012;
Srivastava et al., 2012). Critically, afadin is also necessary for the rapid
remodeling, within 30min, of dendritic spines in response to estradiol
(Srivastava et al., 2008). Interestingly, within this time frame, the re-
modeling of spines by estrogens occur independently of protein
synthesis, and thus are not reliant on gene transcription (Srivastava
et al., 2008). However, the cyto-nuclear shuttling of afadin may inﬂu-
ence gene transcription, although how and whether this results in long-
lasting changes in synaptic structure or function is currently unclear.
Therefore, the increased presence of afadin at synaptic/membrane and
nuclear compartment are likely to play diﬀerent roles.
Multiple studies have shown the that histone H3 is phosphorylated
in response to a variety of stimuli. Importantly, this modiﬁcation has
been established to be suﬃcient to confer a change in chromatin from a
condensed heterochromatin state to a euchromatin state; more amen-
able to gene transcription and associated transcriptional activation
(Berger, 2007; Maze et al., 2013; Watson and Tsai, 2017). H3S10p can
be induced by activity-dependent stimuli, multiple neurotransmitters,
learning and in response to drugs of abuse (Brami-Cherrier et al., 2007,
2009; Chwang et al., 2006; Kumar et al., 2005; Stipanovich et al., 2008;
VanLeeuwen et al., 2014; Wittmann et al., 2009). Regulation of such
nucleosomal events likely controls global and long-lasting changes in
gene transcription, which may ultimately result in established changes
to neuronal structure, and by extension synaptic function.
Previous studies have demonstrated that estrogens can regulate
H3S10p to control cell proliferation in tumour and ovarian cells (Mann
et al., 2011; Ruiz-Cortes et al., 2005). However, in the CNS estrogens
have only been shown to regulate the acetylation of H3 in the CA1
region of the hippocampus; a requirement for estrogen-dependent
memory consolidation (Zhao et al., 2010, 2012). Interestingly, H3S10p
is thought to be able to regulate gene transcription directly, but also to
facilitate the acetylation of H3 (Lo et al., 2000; Maze et al., 2013;
Riccio, 2010; Watson and Tsai, 2017). Future studies will be aimed at
disentangling the potential relationship between these 2 diﬀerent his-
tone modiﬁcations following treatment with estradiol. Indeed, a critical
question is whether H3S10p is required for estradiol-dependent
memory consolidation. Parenthetically, previous studies have shown
that estradiol also increases the phosphorylation of the transcription
factor 'cyclic AMP response element-binding protein’ (CREB) (Boulware
et al., 2005). It would therefore be interesting to determine whether
H3S10p and pCREB induced by acute estradiol exposure, act in concert
or independently.
A surprising ﬁnding in this study, is the potential link between
afadin, ERK/2 and H3S10p. Previous studies have shown that estradiol
rapidly increases pERK1/2 levels in the nucleus (Mannella and Brinton,
2006), and moreover the pERK1/2 is required for estradiol-dependent
increases in pCREB (Boulware et al., 2005). We ﬁnd that like estradiol
treatment, overexpression of afadin also increased pERK1/2 levels
within the nucleus. Critically, increased pERK1/2 levels were also seen
along dendrites, consistent with the spatial distribution of pERK1/2
seen following activation of speciﬁc estrogen receptors (ERs)
(Srivastava et al., 2010). At synaptic sites, afadin has been shown to act
as a scaﬀold protein, allowing components of signalling pathways to
interact (Srivastava et al., 2008, 2012; Xie et al., 2005, 2008). Building
on this, we have previously suggested that one additional function that
afadin may have, is to mediate the transport of signalling proteins to the
nucleus, and/or to act as a scaﬀold to assemble transcription factors or
histone modifying proteins at discrete nuclear subcompartments
(VanLeeuwen et al., 2014). Of note, uncaging of glutamate at a subset
of spines is suﬃcient to cause the translocation of pERK1/2 to the
nucleus (Zhai et al., 2013). In addition to translocating to the nucleus,
pERK1/2 is required for H3S10p in response to multiple stimuli (Brami-
Cherrier et al., 2009; Chwang et al., 2006; Ciccarelli and Giustetto,
2014), and also required for activity-dependent transcriptional
regulation (Bluthgen et al., 2017). It should be noted, however, that a
subset of cells which do not show an increase in afadin nuclear accu-
mulation also show an increase in H3S10p levels, indicating a potential
second, afadin-independent mechanism, linking estradiol with H3
phosphorylation. Nevertheless, one may propose a model whereby
following acute estradiol treatment, pERK1/2 and afadin traﬃc to the
nucleus as a complex, whereupon they increase H3S10p levels (Fig. 6
C). Future studies will be aimed at determining the nature of the rela-
tion between these two proteins.
Taken together, this study provides the ﬁrst evidence that estradiol
can phosphorylate histone h3 in neurons. More speciﬁcally, estradiol
induces the cyto-nuclear traﬃcking of afadin and subsequent nuclear
ERK1/2 activation of H3S10p under stimulated conditions. These data
are consistent with a growing number of studies that demonstrate that
estrogens are capable of modulating gene transcription and protein
synthesis in a non-canonical manner (Choleris et al., 2018; Sellers et al.,
2015a; Srivastava et al., 2013). Moreover, we further provide evidence
that estradiol can promote the bi-directional traﬃcking of afadin to
both synaptic and nuclear compartments; this may underlie how es-
tradiol exerts rapid, as well as long-lasting eﬀects on synaptic structure
and function. Signiﬁcantly, understanding the downstream targets or
gene modulated by this pathway, may reveal how estrogenic-modula-
tion of this cytonuclear pathway may result in long-lasting changes to
synaptic function.
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